<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercebiotech.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Research Reports</title>
 <link>http://www.fiercebiotech.com/research</link>
 <description>Research</description>
 <language>en</language>
<item>
 <title>Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?</title>
 <link>http://www.fiercebiotech.com/research/pipeline-insight-nosocomial-vaccines-minefield-or-goldmine?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;As the reimbursement status for the cost of hospital-acquired infections is under pressure by payors, interest in preventing these complications at the outset is growing. Nosocomial vaccines offer&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/pipeline-insight-nosocomial-vaccines-minefield-or-goldmine&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Fri, 02 May 2008 10:37:51 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">24736 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response</title>
 <link>http://www.fiercebiotech.com/research/drug-approval-trends-fda-and-emea-process-improvements-heightened-scrutiny-and-industry-res?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;Drug approvals in the US and Europe have become subject to approval delays, rising requests for further clinical data, and greater chances of rejection. Regulators are currently attempting to&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/drug-approval-trends-fda-and-emea-process-improvements-heightened-scrutiny-and-industry-res&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Fri, 02 May 2008 10:35:42 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">24735 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Biotech 2008 – life sciences industry report (online &amp; print)</title>
 <link>http://www.fiercebiotech.com/research/biotech-2008-life-sciences-industry-report-online-print?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;Biotech 2008 22nd annual report enables anyone in life sciences to gain a global view on industry financials, key sector activities, important technologies, policies and politics, analysis of deal&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/biotech-2008-life-sciences-industry-report-online-print&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Wed, 30 Apr 2008 09:38:16 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">24365 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Is there a market for alcoholism pharmacotherapies?</title>
 <link>http://www.fiercebiotech.com/research/there-market-alcoholism-pharmacotherapies?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;While competitive intensity in the alcoholism field has been low by traditional measures, MedPredict expects to see tremendous competitive growth after the first successful product&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/there-market-alcoholism-pharmacotherapies&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 17:25:00 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">17424 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>New report provides Rheumatoid Arthritis market insight</title>
 <link>http://www.fiercebiotech.com/research/new-report-provides-rheumatoid-arthritis-market-insight?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;The key issue for MedPredict’s Thought Leader Panel was switching: How long should anti-TNF therapy be tried? What comes next? And what would challenge&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/new-report-provides-rheumatoid-arthritis-market-insight&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 17:20:00 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">17423 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>The Fastest Growing Biotechnology Companies</title>
 <link>http://www.fiercebiotech.com/research/fastest-growing-biotechnology-companies?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;The report examines the structure and organization of the biopharmaceutical industry with a detailed analysis of the fastest growing biopharmaceutical companies. This report provides a comparative&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/fastest-growing-biotechnology-companies&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 14:39:01 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">21775 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Addressing Key Challenges in Drug Safety (Strategic Focus)</title>
 <link>http://www.fiercebiotech.com/research/addressing-key-challenges-drug-safety-strategic-focus?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;High profile drug withdrawals and negative public attention has placed drug safety at the top of the pharmaceutical industry&#039;s agenda. This report will examine pharmacovigilance technology solutions&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/addressing-key-challenges-drug-safety-strategic-focus&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 14:14:31 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">21846 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Pharmaceuticals: Global Industry Guide</title>
 <link>http://www.fiercebiotech.com/research/pharmaceuticals-global-industry-guide?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;Datamonitor&#039;s Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/pharmaceuticals-global-industry-guide&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 14:12:06 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">21845 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>The Future of Targeted Therapeutics</title>
 <link>http://www.fiercebiotech.com/research/future-targeted-therapeutics?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players is a new report published by Business Insights that examines various types of targeted&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/future-targeted-therapeutics&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 08:42:40 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">21777 at http://www.fiercebiotech.com</guid>
</item>
<item>
 <title>Impact of Pharmacogenomics on Public Healthcare Policy</title>
 <link>http://www.fiercebiotech.com/research/impact-pharmacogenomics-public-healthcare-policy?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;During the last fifteen years tremendous advances have been made in deciphering the genetic coding of a variety of species from invertebrates, vertebrates and finally man through the formal&lt;/p&gt;
 &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercebiotech.com/research/impact-pharmacogenomics-public-healthcare-policy&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <pubDate>Tue, 01 Apr 2008 08:40:53 -0400</pubDate>
 <dc:creator>Hada</dc:creator>
 <guid isPermaLink="false">21776 at http://www.fiercebiotech.com</guid>
</item>
</channel>
</rss>
